Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

815
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
815
Long-term Depression01:05

Long-term Depression

27.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
27.3K
Long-term Depression01:03

Long-term Depression

2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Educational Outcomes of a Longitudinal Women's Reproductive Mental Health Elective in Psychiatry Residency Training.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2026
Same author

Current treatment options for perinatal depression.

Current opinion in obstetrics & gynecology·2026
Same author

An intensive outpatient program for patients with perinatal mood and anxiety disorder and their newborns.

General hospital psychiatry·2021
Same author

Mandsager et al. Respond.

American journal of public health·2019
Same author

Factors Associated with State Variation in Mortality Among Persons Living with Diagnosed HIV Infection.

Journal of community health·2019
Same author

Reducing HIV-Related Health Disparities in the Health Resources and Services Administration's Ryan White HIV/AIDS Program.

American journal of public health·2018
Same journal

Folic acid utilization and associated factors among pregnant women who attended public health facilities of illuababor zone, Southwest Ethiopia.

Women's health (London, England)·2026
Same journal

Understanding parents' experiences and needs when managing menstruation with young people with intellectual disability.

Women's health (London, England)·2026
Same journal

Sequential pathway analysis of sex differences in deep brain stimulation for Parkinson's disease.

Women's health (London, England)·2026
Same journal

Couples' optimism, stress, and quality of life when undergoing fertility treatments: A cross-sectional study with prospective outcome assessment.

Women's health (London, England)·2026
Same journal

Global prevalence of domestic violence against adults during COVID-19 and its determinants: A systematic review, meta-analysis, and meta-regression analysis.

Women's health (London, England)·2026
Same journal

Uncovering a hidden modulator for women in sports: An exploratory study of menstrual pain and brain connectivity.

Women's health (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.0K

Managing depression during pregnancy.

Alison Reminick1, Stacy Cohen, Adrienne Einarson

  • 1Center for Women's Behavioral & Mental Health, Rush Medical Center, Chicago, IL, USA.

Women'S Health (London, England)
|October 29, 2013
PubMed
Summary
This summary is machine-generated.

Managing depression during pregnancy is vital for maternal and fetal health. This paper offers evidence-based guidance on screening, risks, and safe antidepressant use for pregnant women.

More Related Videos

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

26.5K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

747

Related Experiment Videos

Last Updated: May 6, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.0K
Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

26.5K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

747

Area of Science:

  • Perinatal mental health
  • Reproductive psychiatry
  • Obstetrics and Gynecology

Background:

  • Depression during pregnancy is common but often overlooked, impacting maternal and fetal well-being.
  • Barriers to treatment include mental health stigma and conflicting evidence on antidepressant safety in pregnancy.
  • Untreated depression poses risks to both mother and baby, necessitating effective management strategies.

Purpose of the Study:

  • To provide evidence-based recommendations for managing depression in pregnant women.
  • To address challenges in treatment, including screening, risks, and pharmaceutical safety.
  • To offer a clinical algorithm for informed decision-making in perinatal depression.

Main Methods:

  • Review of current evidence on depression management during pregnancy.
  • Evaluation of risks associated with untreated depression and antidepressant use.
  • Development of a treatment algorithm for clinical decision support.

Main Results:

  • Identification of key management components: screening, risk assessment, and safety evaluation of treatments.
  • A proposed treatment algorithm to guide clinicians through complex decisions.
  • Emphasis on individualized, case-by-case patient evaluation.

Conclusions:

  • Effective management of depression during pregnancy is crucial for optimal maternal and infant outcomes.
  • An evidence-based approach, supported by a clinical algorithm, can improve care.
  • Individualized assessment is paramount in ensuring the best results for mother and child.